EVALUATION OF ANTIOXIDANT, ANTIMICROBIAL, AND ANTIFUNGAL POTENTIAL OF CUCURBITA PEPO VAR. FASTIGATA SEED EXTRACTS

Objective: The current study aims to study the antioxidant and antimicrobial and antifungal potential of the methanolic extract of Cucurbita pepo var. fastigata seeds (MECS). Methods: Extraction of the seeds has been carried out with solvents of increasing polarity (chloroform, acetone, and methanol) and the phytochemical study of the methanolic extract have been carried out using standard methods. The free radical scavenging activity of all the extracts was evaluated by DPPH and H2O2 methods. Standard disk diffusion method was used to evaluate antibacterial and antifungal activities. Results: Phytochemical evaluation showed the maximum presence of triterpenoids, phenolic compounds, tannins and small amount of Coumarins. Methanolic extract revealed momentous antioxidant activity as compared to chloroform and ethyl acetate extract. Hence, methanolic extract of C. pepo. seeds (MECS) at a dose level of 100, 200 and 300 μg/ml was evaluated for antioxidant potential. Maximum free radical scavenging activity of methanolic seed extract of cucurbita pepo var. fastigata has been found at a dose of 300 μg/ml to be 63±0.16 % by 1,1-diphenyl-2-picryl hydrazyl model and at a value of 78% at 300 μg/ml with H2O2 model. Methanolic extract also showed the presence of antibacterial activity. Conclusion: Presence of phytochemicals in the methanolic extract is responsible for the antioxidant potential. Extracts were investigated for antibacterial activity using the standard disc diffusion assay method against Bacillus subtilis, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa and for the antifungal activities against Aspergillus niger and Candida albicans. The seed extract showed the presence of antibacterial activity, but the antifungal activity was found to be absent in the extract

Evaluation of antioxidant and anti-ulcerative potential of Citrullus lanatus seed extract in rats

In the present study antioxidant and antiulcer potential of Citrullus lanatus seeds were evaluated. Antioxidant activity of all the extracts (chloroform, ethylacetate and methanol) was measured by DPPH method. Methanolic extract of Citrullus lanatus (MECL) seeds showed maximum antioxidant potential and was evaluated for its anti-ulcerogenic activity by pyloric ligated (PL) and water immersion stress (WIS) induced ulcer models in rat. Gastric volume and free and total acidity were measured in PL model whereas; ulcerative index was measured in both the models at 100, 200 and 300 mg/kg doses of MECL. Rats treated with MECL (300 mg/kg) showed significant decrease in the gastric volume, free acidity and total acidity in case of PL model and showed significant percentage inhibition of ulcer as indicated by decrease in ulcerative index in both the models. The extract of Citrullus lanatus seeds possesses good antioxidant and anti-ulcer activity.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Evaluation of antioxidant and anti-ulcerative potential of Citrullus lanatus seed extract in rats

In the present study antioxidant and antiulcer potential of Citrullus lanatus seeds were evaluated. Antioxidant activity of all the extracts (chloroform, ethylacetate and methanol) was measured by DPPH method. Methanolic extract of Citrullus lanatus (MECL) seeds showed maximum antioxidant potential and was evaluated for its anti-ulcerogenic activity by pyloric ligated (PL) and water immersion stress (WIS) induced ulcer models in rat. Gastric volume and free and total acidity were measured in PL model whereas; ulcerative index was measured in both the models at 100, 200 and 300 mg/kg doses of MECL. Rats treated with MECL (300 mg/kg) showed significant decrease in the gastric volume, free acidity and total acidity in case of PL model and showed significant percentage inhibition of ulcer as indicated by decrease in ulcerative index in both the models. The extract of Citrullus lanatus seeds possesses good antioxidant and anti-ulcer activity.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Evaluation of antioxidant and anti-ulcerative potential of Citrullus lanatus seed extract in rats

In the present study antioxidant and antiulcer potential of Citrullus lanatus seeds were evaluated. Antioxidant activity of all the extracts (chloroform, ethylacetate and methanol) was measured by DPPH method. Methanolic extract of Citrullus lanatus (MECL) seeds showed maximum antioxidant potential and was evaluated for its anti-ulcerogenic activity by pyloric ligated (PL) and water immersion stress (WIS) induced ulcer models in rat. Gastric volume and free and total acidity were measured in PL model whereas; ulcerative index was measured in both the models at 100, 200 and 300 mg/kg doses of MECL. Rats treated with MECL (300 mg/kg) showed significant decrease in the gastric volume, free acidity and total acidity in case of PL model and showed significant percentage inhibition of ulcer as indicated by decrease in ulcerative index in both the models. The extract of Citrullus lanatus seeds possesses good antioxidant and anti-ulcer activity.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Potential effect of Citrus decumana extract on stress induced peptic ulcer in rat

The present study was designed to investigate the antiulcer activity of ethyl acetate extract of Citrus decumana (grapefruit) peels. The antiulcerogenic activity was evaluated in water immersion and hypothermic restraint stress models at different doses (150, 250 and 350 mg/kg). The antiulcer potential of the extract was assessed by determining and comparing the ulcerative index and biochemical estimation was carried out using various oxidative stress markers i.e., TBARS, GSH, SOD and CAT in the blood and tissue samples. The highest dose (350 mg/kg) of the extract showed significant decrease in the ulcerative index and TBARS level, whereas there was increase in the GSH, SOD and CAT levels. Whereas the lowest and medium dose (150 mg/kg and 250mg/kg) did not produce any significant results. Therefore, our study indicate that the Citrus decumana peel extract may be used as a natural therapeutic agent in the treatment of peptic ulcers.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Fenugreek derived diosgenin as an emerging source for diabetic therapy

Diabetes is a chronic metabolic disease that endangers the entire body’s tissues and organs. Diabetes impairs glucose and insulin regulation in the human body by causing pancreatic cell damage. Diabetes modifies pathways such as serine/threonine protein kinase (Akt) and Protein kinase C (PKC)/- glucose transporter 4 (GLUT4), peroxisome proliferator-activated receptor (PPAR) glucose absorption, and inhibits α-amylase and α-glucosidase, Sodium/glucose cotransporter 1 (SGLT-1), and Na+-K+-ATPase activity. Diabetes may also be caused by a decrease in the expression of sterol regulatory element binding protein 1 (SREBP-1) and its target genes, fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and acetyl-CoA carboxylase α (ACC), as well as a decrease in the levels of C/EBP homologous protein (CHOP), Caspase12, and Caspase3 proteins. Diabetes has long been linked to diseases of the cardiovascular, nervous, skeletal, reproductive, hepatic, ocular, and renal systems. Diosgenin, a steroidal compound derived from fenugreek, aids in the prevention of diabetes by altering cellular pathways in favor of healthy bodily functions. Diosgenin is a new nutraceutical on the market that claims to cure diabetes in particular. This article focuses on diosgenin extraction and purification, fenugreek bioactive compounds, pharmacological properties of diosgenin, mode of action of diosgenin to cure diabetes, and dosages

Antioxidant, anti-inflammatory and analgesic potential of Cucumis sativus seed extract

In the present study antioxidant, anti-inflammatory and analgesic potential of the methanolic extract of Cucumis sativus seeds was evaluated. Extraction of the seeds was carried out using solvents of increasing polarity. The free radical scavenging activity of all the extracts was measured by DPPH and H2O2 methods. Methanolic extract of the seeds had shown significant antioxidant activity as compared to chloroform and ethyl acetate extract. Hence, methanolic extract of C. sativus seeds (MECS) at a dose level of 100, 200 and 300 mg/kg was further evaluated for its in vivo anti-inflammatory activity using carrageenan induced rat paw edema and analgesic activity by tail flick and tail immersion methods. Results were obtained in a dose dependent manner. MECS (300 mg/kg) had shown significant (p < 0.05) anti-inflammatory and analgesic activity as compared to diclofenac sodium and morphine, respectively. From the results it may be concluded that MECS have good antioxidant, anti-inflammatory and analgesic potential.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017 : a systematic analysis for the Global Burden of Disease Study 2017

Background Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017. Methods The causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODErn), to generate cause fractions and cause specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised. Findings At the broadest grouping of causes of death (Level 1), non-communicable diseases (NC Ds) comprised the greatest fraction of deaths, contributing to 73.4% (95% uncertainty interval [UI] 72.5-74.1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional (CMNN) causes accounted for 186% (17.9-19.6), and injuries 8.0% (7.7-8.2). Total numbers of deaths from NCD causes increased from 2007 to 2017 by 22.7% (21.5-23.9), representing an additional 7.61 million (7. 20-8.01) deaths estimated in 2017 versus 2007. The death rate from NCDs decreased globally by 7.9% (7.08.8). The number of deaths for CMNN causes decreased by 222% (20.0-24.0) and the death rate by 31.8% (30.1-33.3). Total deaths from injuries increased by 2.3% (0-5-4-0) between 2007 and 2017, and the death rate from injuries decreased by 13.7% (12.2-15.1) to 57.9 deaths (55.9-59.2) per 100 000 in 2017. Deaths from substance use disorders also increased, rising from 284 000 deaths (268 000-289 000) globally in 2007 to 352 000 (334 000-363 000) in 2017. Between 2007 and 2017, total deaths from conflict and terrorism increased by 118.0% (88.8-148.6). A greater reduction in total deaths and death rates was observed for some CMNN causes among children younger than 5 years than for older adults, such as a 36.4% (32.2-40.6) reduction in deaths from lower respiratory infections for children younger than 5 years compared with a 33.6% (31.2-36.1) increase in adults older than 70 years. Globally, the number of deaths was greater for men than for women at most ages in 2017, except at ages older than 85 years. Trends in global YLLs reflect an epidemiological transition, with decreases in total YLLs from enteric infections, respirator}, infections and tuberculosis, and maternal and neonatal disorders between 1990 and 2017; these were generally greater in magnitude at the lowest levels of the Socio-demographic Index (SDI). At the same time, there were large increases in YLLs from neoplasms and cardiovascular diseases. YLL rates decreased across the five leading Level 2 causes in all SDI quintiles. The leading causes of YLLs in 1990 neonatal disorders, lower respiratory infections, and diarrhoeal diseases were ranked second, fourth, and fifth, in 2017. Meanwhile, estimated YLLs increased for ischaemic heart disease (ranked first in 2017) and stroke (ranked third), even though YLL rates decreased. Population growth contributed to increased total deaths across the 20 leading Level 2 causes of mortality between 2007 and 2017. Decreases in the cause-specific mortality rate reduced the effect of population growth for all but three causes: substance use disorders, neurological disorders, and skin and subcutaneous diseases. Interpretation Improvements in global health have been unevenly distributed among populations. Deaths due to injuries, substance use disorders, armed conflict and terrorism, neoplasms, and cardiovascular disease are expanding threats to global health. For causes of death such as lower respiratory and enteric infections, more rapid progress occurred for children than for the oldest adults, and there is continuing disparity in mortality rates by sex across age groups. Reductions in the death rate of some common diseases are themselves slowing or have ceased, primarily for NCDs, and the death rate for selected causes has increased in the past decade. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd.Peer reviewe